Get the Stockscreener App
13.97
1.31%
0.18
After Hours:
13.95
-0.02
-0.14%
Lumexa Imaging Holdings Inc stock is traded at $13.97, with a volume of 560.62K.
It is up +1.31% in the last 24 hours and down -11.69% over the past month.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities including MRIs, CT scans, PET scans, X-rays, ultrasounds, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated from the Outpatient segment, which generates revenue by performing imaging studies and providing radiologists' interpretations of those studies.
See More
Previous Close:
$13.79
Open:
$13.65
24h Volume:
560.62K
Relative Volume:
1.45
Market Cap:
$1.32B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+37.77%
1M Performance:
-11.69%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$13.45
$14.37
1-Week Range:
$10.21
$14.37
52-Week Range:
$9.965
$19.45
Lumexa Imaging Holdings Inc Stock (LMRI) Company Profile
Name
Lumexa Imaging Holdings Inc
Sector
Industry
Phone
-
Address
-
Compare LMRI vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LMRI
Lumexa Imaging Holdings Inc
|
13.97 | 1.30B | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Lumexa Imaging Holdings Inc Stock (LMRI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-26 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-05-26 | Initiated | Barclays | Overweight |
| Jan-05-26 | Initiated | Deutsche Bank | Buy |
| Jan-05-26 | Initiated | JP Morgan | Overweight |
| Jan-05-26 | Initiated | Jefferies | Buy |
| Jan-05-26 | Initiated | Leerink Partners | Outperform |
| Jan-05-26 | Initiated | Raymond James | Outperform |
| Jan-05-26 | Initiated | Wells Fargo | Overweight |
| Jan-05-26 | Initiated | William Blair | Outperform |
View All
Lumexa Imaging Holdings Inc Stock (LMRI) Latest News
Wall Street Analysts Are Bullish on Top Technology Picks - The Globe and Mail
Lumexa Imaging (NASDAQ:LMRI) Rating Increased to Strong-Buy at Raymond James Financial - Defense World
LMRI Lumexa Imaging Holdings, Inc. Common Stock Strong Buy Raymond James Feb 2026 - Meyka
Lumexa Imaging (NASDAQ:LMRI) Raised to "Strong-Buy" at Raymond James Financial - MarketBeat
FinancialContentLumexa Imaging Holdings, Inc.Common Stock (Nasdaq:LMRI) Stock Quote - FinancialContent
Lumexa Imaging's Dr. Jennifer L. Kemp Elected to RSNA Board, Advancing National Leadership in Quality and Patient-Centered Care - The Malaysian Reserve
Lumexa Imaging's Dr. Jennifer L. Kemp Elected to RSNA Board, Adv - GuruFocus
Lumexa Imaging’s Dr. Kemp elected to RSNA board By Investing.com - Investing.com Canada
Lumexa Imaging Holdings, Inc.’s Quiet Period Set To End on January 20th (NASDAQ:LMRI) - Defense World
Lumexa Imaging Holdings chief legal officer Julie Szeker to resign in March - Investing.com Nigeria
Lumexa Imaging Holdings, Inc. Announces Resignation of Chief Legal Officer and Corporate Secretary Julie Szeker, Effective March 13, 2026 - marketscreener.com
Lumexa Imaging Holdings chief legal officer Julie Szeker to resign in March By Investing.com - Investing.com South Africa
Lumexa Imaging Announces Chief Legal Officer Resignation - TipRanks
Assessing Lumexa Imaging Holdings (LMRI) Valuation After Recent Share Price Pullback - Yahoo Finance
Lumexa Imaging Holdings Grants $450,000 Transition Payment and Bonus to Departing Chief Legal Officer - Longbridge
LMRI: Global radiopharma leader drives growth with late-stage oncology pipeline and strategic expansion - TradingView — Track All Markets
Lumexa Imaging: Resilient Demand With Compounding Scale Moat (NASDAQ:LMRI) - Seeking Alpha
Lumexa Imaging Holdings, Inc.Common Stock (NQ: LMRI - FinancialContent
Lumexa Imaging Achieves Record De Novo Expansion in 2025 - Sahm
Lumexa Imaging Holdings, Inc.: Revenue and Earnings Analysts Forecasts Revisions | LMRI | US5502491062 - MarketScreener
Lumexa Imaging Holdings, Inc.: Target Price Consensus and Analysts Recommendations | LMRI | US5502491062 - MarketScreener
Lumexa Imaging Holdings, Inc.: Dividend historical data and projections - MarketScreener
Analysts Offer Insights on Technology Companies: Advanced Micro Devices (AMD) and Lumexa Imaging Holdings, Inc. (LMRI) - The Globe and Mail
Analysts Offer Insights on Technology Companies: Broadcom (AVGO), Lumexa Imaging Holdings, Inc. (LMRI) and Apple (AAPL) - The Globe and Mail
Lumexa Imaging Holdings: Leveraging Outpatient Growth and JV Model to Drive Premium-Valued Expansion and Deleveraging Upside - TipRanks
Lumexa Imaging Announces Participation in Upcoming January 2026 Investor Conference - BioSpace
Lumexa Imaging Announces Participation in Upcoming Investor Conf - GuruFocus
Lumexa Imaging Announces Participation in Upcoming Investor Conference - Finviz
Lumexa Imaging Holdings: Secular Tailwinds, High-Return Expansion, and Joint-Venture Model Support Buy Rating - TipRanks
Lumexa Imaging Draws Bullish Analyst Calls On Heels Of IPO - One News Page
Deutsche Bank Initiates Lumexa Imaging at Buy With $22 Price Target - marketscreener.com
Deutsche Bank initiates coverage on Lumexa Imaging stock with Buy rating - Investing.com Canada
JPMorgan Initiates Lumexa Imaging at Overweight With $23 Price Target - marketscreener.com
Jefferies Initiates Lumexa Imaging at Buy With $23 Price Target - marketscreener.com
Barclays Initiates Lumexa Imaging at Overweight With $23 Price Target - marketscreener.com
Leerink Partners Initiates Lumexa Imaging at Outperform With $23 Price Target - marketscreener.com
This vTv Therapeutics Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
LMRI Archives - 24/7 Wall St.
Wells Fargo initiates Lumexa Imaging stock with Overweight rating By Investing.com - Investing.com Canada
Lumexa Imaging stock initiated with Outperform rating by William Blair - Investing.com
Lumexa Imaging Holdings: Capitalizing on Outpatient Imaging Tailwinds with Sustainable Growth and Attractive Risk-Reward - TipRanks
Jefferies initiates coverage on Lumexa Imaging stock with Buy rating By Investing.com - Investing.com Nigeria
JPMorgan initiates Lumexa Imaging stock with Overweight rating, $23 target By Investing.com - Investing.com Canada
Jefferies initiates coverage on Lumexa Imaging stock with Buy rating - Investing.com
Lumexa Imaging Holdings Inc Stock (LMRI) Financials Data
There is no financial data for Lumexa Imaging Holdings Inc (LMRI). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.45%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):